MedPath

BAYSHORE PHARMACEUTICALS LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

FDA:17

Drug Approvals

Nadolol

Approval Date
Apr 4, 2024
FDA

Methocarbamol

Approval Date
Jan 17, 2024
FDA

Sotalol Hydrochloride

Approval Date
Jan 17, 2024
FDA

Sotalol

Approval Date
Jan 17, 2024
FDA

Metformin hydrochloride

Approval Date
Jan 17, 2024
FDA

Cyproheptadine Hydrochloride

Approval Date
Jan 17, 2024
FDA

Carvedilol

Approval Date
Jan 11, 2024
FDA

Flecainide Acetate

Approval Date
Jan 11, 2024
FDA

Primaquine Phosphate

Approval Date
Jan 9, 2024
FDA

Diphenoxylate Hydrochloride and Atropine Sulfate

Approval Date
Jan 8, 2024
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.